(2023)
External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion.
RADIOTHERAPY AND ONCOLOGY.
187,
(2023)
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.
JHEP REPORTS.
5,
9
(2023)
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B.
SCIENTIFIC REPORTS.
13,
1
(2023)
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective.
CLINICAL AND MOLECULAR HEPATOLOGY.
29,
2
(2022)
Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.
KOREAN JOURNAL OF INTERNAL MEDICINE.
37,
5
(2022)
Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
DIGESTIVE DISEASES AND SCIENCES.
67,
9
(2022)
Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular.
KOREAN JOURNAL OF RADIOLOGY.
23,
6
(2022)
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.
SCIENTIFIC REPORTS.
12,
1
(2022)
Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment.
PLOS ONE.
17,
1
(2022)
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
GENOME MEDICINE.
14,
1
(2022)
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY.
34,
1
(2022)
Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY.
57,
1
(2021)
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.
HEPATOLOGY.
74,
6
(2021)
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY.
147,
12
(2021)
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response.
JOURNAL OF VIRAL HEPATITIS.
28,
10
(2021)
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.
HEPATOLOGY INTERNATIONAL.
15,
4
(2021)
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
DIGESTIVE DISEASES AND SCIENCES.
66,
8
(2021)
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.
DIGESTIVE AND LIVER DISEASE.
53,
8
단행본
(2017)
HARRISON'S 내과학.
도서출판MIP.
공동
(2016)
소화기계 질환.
일조각.
공동
(2005)
[간염 제 2판] 바이러스성 간염과 간이식.
군자출판사.
공동
학술회의논문
(2017)
Clinical Characteristics, Potencial Etiology and Mode of Detection for Non-B Non-C Hepatocellular Carcinoma in Korea.
KDDW 2017.
대한민국
(2017)
Comparison of Treatment Efficacy between Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) in Treatment-naive Chronic Hepatitis B Patients: Long-term Real-world Experience.
KDDW 2017.
대한민국
(2017)
Comparison of Methods to Estimate Liver Function in Newly-
Diagnosed Hepatocellular Carcinoma Patients with Ascites.
The Liver Week 2017.
대한민국
(2017)
Efficacy and Safety of Ledipasvir/Sofosbuvir Therapy in HCV
Genotype 1 Korean Patients.
The Liver Week 2017.
대한민국
(2017)
Efficacy and Safety of Sofosbuvir plus Ribavirin Therapy
in Treatment-Naïve and Treatment-Experienced Korean
Patients with Genotype 2 Chronic HCV Infection: A
Single-Center, Real-Life Experience.
The Liver Week 2017.
대한민국
(2017)
Efficacy of Daclatasvir plus Asunaprevir Therapy in Korean
Patients with Genotype 1b Chronic HCV Infection: Virologic
Response and Liver Fibrosis.
The Liver Week 2017.
대한민국
(2017)
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model
for Patients with Hepatocellular Carcinoma Undergoing
Chemoembolization.
The Liver Week 2017.
대한민국
(2017)
Nutritional Support Team Approach Decreases In-Hospital
Mortality after Deceased Donor Liver Transplantation.
The Liver Week 2017.
대한민국
(2017)
Performance of Fibrosis Markers for Hepatocellular Carcinoma
Development in Chronic Hepatitis B Patients under
Antiviral Therapy.
The Liver Week 2017.
대한민국
(2016)
Prognosis of early stage hepatocellular carcinoma showing complete response after first transarterial chemoembolization:a role of scheduled second TACE.
UEGW.
오스트리아
(2016)
Albumin-bilirubin grade and long-term survival in very early stage hepatocellular carcinoma who received either resection or ablation.
APPLE.
홍콩
(2016)
Albumin-bilirubin grade and long-term survival in very early stage hepatocellular carcinoma who received either resection or ablation.
The liver week 2016.
대한민국
(2016)
Primary prophylaxis for variceal bleeding should be done for patients with hepatocellular carcinoma.
EASL.
스페인
(2016)
Elimination of Hepatitis C Virus (HCV) in South Korea.
APASL.
대한민국
(2016)
Work productivity impairment in asian patients with hepatitis C treated with different regimens.
APASL.
대한민국
(2015)
Locoregional therapy or liver transplantation forhepatocellular carcinoma fulfilling the Milan criteria.
소화기학회.
대한민국
(2015)
MOCC:북한 의료인 교육을 위한 활용 방안.
소화기학회.
대한민국
(2015)
Discontinuation of Antiviral prophylaxis in Hepatitis B Virus Infected Patients Who Received Cytotoxic Chemotherapy: Outcomes and Predictors.
AASLD.
미국
(2015)
Survival of hepatocellular carcinoma patients according to recommended treatment by the Barcelona Clinic Liver Cancer or Hong Kong Liver Cancer staging system in hepatitis B endemic area.
AASLD.
미국
(2015)
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels..
AASLD.
미국
